INPP4B Promotes PI3Kα-dependent Late Endosome Formation and Wnt/β-catenin Signaling in Breast Cancer
Overview
Authors
Affiliations
INPP4B suppresses PI3K/AKT signaling by converting PI(3,4)P to PI(3)P and INPP4B inactivation is common in triple-negative breast cancer. Paradoxically, INPP4B is also a reported oncogene in other cancers. How these opposing INPP4B roles relate to PI3K regulation is unclear. We report PIK3CA-mutant ER breast cancers exhibit increased INPP4B mRNA and protein expression and INPP4B increased the proliferation and tumor growth of PIK3CA-mutant ER breast cancer cells, despite suppression of AKT signaling. We used integrated proteomics, transcriptomics and imaging to demonstrate INPP4B localized to late endosomes via interaction with Rab7, which increased endosomal PI3Kα-dependent PI(3,4)P to PI(3)P conversion, late endosome/lysosome number and cargo trafficking, resulting in enhanced GSK3β lysosomal degradation and activation of Wnt/β-catenin signaling. Mechanistically, Wnt inhibition or depletion of the PI(3)P-effector, Hrs, reduced INPP4B-mediated cell proliferation and tumor growth. Therefore, INPP4B facilitates PI3Kα crosstalk with Wnt signaling in ER breast cancer via PI(3,4)P to PI(3)P conversion on late endosomes, suggesting these tumors may be targeted with combined PI3K and Wnt/β-catenin therapies.
The essential clathrin adapter protein complex-2 is tumor suppressive specifically in vivo.
Zimmerman S, DeGraw L, Counter C Nat Commun. 2025; 16(1):2254.
PMID: 40050266 PMC: 11885535. DOI: 10.1038/s41467-025-57521-2.
Class I PI3Ks activate stretch-induced autophagy in trabecular meshwork cells.
Shim M, Sim E, Betsch K, Desikan V, Su C, Pastor-Valverde D Cell Mol Life Sci. 2025; 82(1):82.
PMID: 39985671 PMC: 11846827. DOI: 10.1007/s00018-025-05615-x.
PTPN23-dependent activation of PI3KC2α is a therapeutic vulnerability of BRAF-mutant cancers.
He Y, Li W, Zhang M, Wang H, Lin P, Yu Y J Exp Med. 2025; 222(3.
PMID: 39841180 PMC: 11753290. DOI: 10.1084/jem.20241147.
A novel micropeptide miPEP205 suppresses the growth and metastasis of TNBC.
Zhang Z, Li F, Dai X, Deng J, Wang Y, Zhang S Oncogene. 2024; 44(8):513-529.
PMID: 39623077 DOI: 10.1038/s41388-024-03240-9.
Vicente-Munoz S, Davis J, Lane A, Lane A, Waltz S, Wells S Front Oncol. 2024; 14:1382986.
PMID: 39351361 PMC: 11440356. DOI: 10.3389/fonc.2024.1382986.